Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C3.ai Inc (Class A) | Edward Y. Abbo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,200,000 | 1,200,000 | - | - | Restricted Stock Units | |
| C3.ai Inc (Class A) | Houman Behzadi | Chief Product Officer | 22 Jun 2022 | 1,200,000 | 1,200,000 | - | - | Restricted Stock Units | ||
| Scholar Rock Holding Corp | Amir H. Nashat | Director | Purchase of securities on an exchange or from another person at price $ 4.90 per share. | 22 Jun 2022 | 1,131,850 | 3,540,530 (11%) | 3% | 4.9 | 5,546,065 | Common Stock |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,048,723 | 1,048,723 | - | - | Stock Options | |
| GoHealth Inc (Class A) | Shane E. Cruz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 800,000 | 2,607,128 | - | 0 | Class A Common Stock | |
| Grace Therapeutics Inc | Janelle D'Alvise | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 560,000 | 560,000 | - | - | Stock Options (Right to Buy) | |
| GoHealth Inc (Class A) | Brian P. Farley | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 500,000 | 1,616,547 | - | 0 | Class A Common Stock | |
| Scholar Rock Holding Corp | Amir H. Nashat | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2022 | 282,962 | 282,962 | - | - | Common Warrant (right to buy) | |
| C3.ai Inc (Class A) | Juho Parkkinen | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 200,000 | 368,755 | - | 0 | Class A Common Stock | |
| Coursera Inc | Leah F. Belsky | See Remarks | Sale of securities on an exchange or to another person at price $ 15.63 per share. | 22 Jun 2022 | 200,000 | 466,580 | - | 15.6 | 3,125,480 | Common Stock |
| Salesforce | Marc Benioff | Director, Chairman and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 190,818 | 190,818 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Salesforce | Bret Taylor | Director, Vice Chair of the Board, CoCEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 190,818 | 190,818 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Grace Therapeutics Inc | Brian D. Ford | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 165,000 | 165,000 | - | - | Stock Options (Right to Buy) | |
| Grace Therapeutics Inc | Pierre Lemieux | COO, Canada & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 165,000 | 165,000 | - | - | Stock Options (Right to Buy) | |
| Invivyd Inc | Clive A. Meanwell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Marc Elia | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Tamsin Berry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 149,818 | 149,818 | - | - | Stock Options | |
| BridgeBio Pharma Inc | Charles J. Homcy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Fred Hassan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | James C. Momtazee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Richard H. Scheller | Director | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | ||
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Ali J. Satvat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Douglas A. Dachille | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Jennifer Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Ronald J. Daniels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Andrew W. Lo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Hannah A. Valantine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Andrea John Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| Greenwich LifeSciences Inc | Frank Joseph Daugherty | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,890 | 104,890 | - | - | Stock Options | |
| TeraWulf Inc | Steven T. Pincus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 101,260 | 101,260 | - | - | Restricted Stock Units | |
| LoanDepot Inc (Class A) | Jeff DerGurahian | Chief Capital Markets Officer | Sale of securities on an exchange or to another person at price $ 1.47 per share. | 22 Jun 2022 | 100,000 | 7,042,969 (11%) | 0% | 1.5 | 146,760 | Class A Common Stock |
| Praxis Precision Medicines Inc | Marcio Souza | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Christopher Bowden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| ImageneBio Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 5.37 per share. | 22 Jun 2022 | 96,035 | 2,098,097 | - | 5.4 | 515,708 | Common Stock |
| JBG SMITH Properties | W. Matthew Kelly | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 22 Jun 2022 | 86,105 | 4,622 (0%) | 0% | 0 | Common Shares | |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 80,000 | 188,333 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 80,000 | 188,333 (0%) | 0% | 0 | Common Stock | |
| DocuSign Inc | Daniel D. Springer | Director | 22 Jun 2022 | 79,566 | 1,704,656 (0%) | 0% | 0 | Common Stock | ||
| TeraWulf Inc | Jason G. New | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 79,248 | 79,248 | - | - | Restricted Stock Units | |
| TeraWulf Inc | Walter E. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 79,248 | 79,248 | - | - | Restricted Stock Units | |
| TeraWulf Inc | Catherine J. Motz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 79,248 | 79,248 | - | - | Restricted Stock Units | |
| TeraWulf Inc | Lisa A. Prager | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 79,248 | 79,248 | - | - | Restricted Stock Units | |
| Salesforce | Marc Benioff | Director, Chairman and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 78,906 | 78,906 | - | - | Performance-Based Restricted Stock Units | |
| Salesforce | Bret Taylor | Director, Vice Chair of the Board, CoCEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 78,906 | 78,906 | - | - | Performance-Based Restricted Stock Units | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 77,534 | 5,393,243 | - | - | Stock Option (Right to Purchase) | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 22 Jun 2022 | 77,534 | 199,273 | - | 2 | 155,068 | Common Stock, $0.01 par value per share |
| First Citizens Bancshares Inc (NC) (Class A) | Hope Holding Bryant | Director, Vice Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2022 | 76,200 | 0 | - | 0 | Class B Common Stock | |
| Invivyd Inc | Michael Stephen Wyzga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Terrance G. Mcguire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Howard Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Tomas J. Heyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| First Citizens Bancshares Inc (NC) (Class A) | Hope Holding Bryant | Director, Vice Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2022 | 71,700 | 0 (0%) | 0% | 0 | Class A Common Stock | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 69,843 | 5,470,777 | - | - | Stock Option (Right to Purchase) | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 22 Jun 2022 | 69,843 | 191,582 | - | 2 | 139,686 | Common Stock, $0.01 par value per share |
| TeraWulf Inc | Michael C. Bucella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 67,703 | 67,703 | - | - | Restricted Stock Units | |
| ImageneBio Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 3.55 per share. | 22 Jun 2022 | 66,806 | 1,912,678 | - | 3.5 | 237,161 | Common Stock |
| Scholar Rock Holding Corp | Amir H. Nashat | Director | Purchase of securities on an exchange or from another person at price $ 4.90 per share. | 22 Jun 2022 | 66,142 | 206,897 (0%) | 0% | 4.9 | 324,096 | Common Stock |
| ImageneBio Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 4.37 per share. | 22 Jun 2022 | 65,965 | 2,002,062 | - | 4.4 | 288,267 | Common Stock |
| Praxis Precision Medicines Inc | Bernard Ravina | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Nicole Sweeny | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| C3.ai Inc (Class A) | Edward Y. Abbo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 64,588 | 64,588 | - | - | Restricted Stock Units | |
| C3.ai Inc (Class A) | Houman Behzadi | Chief Product Officer | 22 Jun 2022 | 64,588 | 64,588 | - | - | Restricted Stock Units | ||
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.12 per share. | 22 Jun 2022 | 64,321 | 127,261 | - | 29.1 | 1,873,092 | Common Stock, $0.01 par value per share |
| Greenwich LifeSciences Inc | David B. McWilliams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 61,984 | 61,984 | - | - | Stock Options | |
| Erasca Inc | Michael D. Varney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Tempest Therapeutics Inc | Samuel Whiting | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 55,680 | 55,680 | - | - | Stock Option (Right to Buy) | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.68 per share. | 22 Jun 2022 | 50,086 | 121,739 | - | 29.7 | 1,486,502 | Common Stock, $0.01 par value per share |
| Grace Therapeutics Inc | George Kottayil | COO, US | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 50,000 | 50,000 | - | - | 06/22/2022 | |
| JBG SMITH Properties | W. Matthew Kelly | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2022 | 47,673 | 47,673 (0%) | 0% | 0 | Common Shares | |
| Biomea Fusion Inc | Elizabeth Faust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 45,755 | 45,755 | - | - | Stock Option (Right to Buy) | |
| Invivyd Inc | Redonda Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 44,178 | 44,178 | - | - | Stock Option (Right to Buy) | |
| Greenwich LifeSciences Inc | Eric Rothe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 41,349 | 41,349 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 41,349 | 41,349 | - | - | Stock Options | |
| NextNav Inc | Bandel L. Carano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 41,170 | 62,652 | - | 0 | Common Stock | |
| NextNav Inc | Gary M. Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 41,170 | 1,709,123 | - | 0 | Common Stock | |
| NextNav Inc | Peter D. Aquino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 41,170 | 242,467 | - | 0 | Common Stock | |
| NextNav Inc | Peter J. Barris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 41,170 | 57,282 | - | 0 | Common Stock | |
| NextNav Inc | Alan B. Howe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 41,170 | 82,282 | - | 0 | Common Stock | |
| Erasca Inc | Alexander W. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Erasca Inc | Julie Hambleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Erasca Inc | Pratik S. Multani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Erasca Inc | James A. Bristol | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Erasca Inc | Valerie Harding Start | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Erasca Inc | Bihua Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Christopher Bowden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 44,167 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 45,000 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 45,000 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Jaime Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 745,321 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Holger Weis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 160,167 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 1,241,870 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 1,241,870 (0%) | 0% | 0 | Common Stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 22 Jun 2022 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 22 Jun 2022 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 4,187,155 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 4,227,155 | - | - | Stock Option (Right to Buy) | |
| Coursera Inc | Leah F. Belsky | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.23 per share. | 22 Jun 2022 | 38,790 | 630,370 | - | 2.2 | 86,502 | Common Stock |
| Coursera Inc | Leah F. Belsky | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 38,790 | 16,667 | - | - | Stock Option (right to buy) | |
| JBG SMITH Properties | W. Matthew Kelly | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2022 | 38,432 | 38,432 (0%) | 0% | 0 | Common Shares | |
| Coursera Inc | Leah F. Belsky | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. | 22 Jun 2022 | 36,210 | 666,580 | - | 6.3 | 228,123 | Common Stock |
| Coursera Inc | Leah F. Belsky | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 36,210 | 67,417 | - | - | Stock Option (right to buy) | |
| Braze Inc (Class A) | Jonathan Hyman | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 36,192 | 1,811,599 | - | - | Class B Common Stock | |
| Braze Inc (Class A) | Jonathan Hyman | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 36,192 | 8,757 | - | - | Stock Option (Right to Buy) | |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Kurt C. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Willard H. Dere | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Gregory Behar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Paul R. Biondi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Meryl S. Zausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Meryl S. Zausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Kingsway Fin Services Inc | Terence M. Kavanagh | Director | Purchase of securities on an exchange or from another person at price $ 5.31 per share. | 22 Jun 2022 | 34,660 | 2,547,146 (11%) | 0% | 5.3 | 183,996 | Commoon Stock |
| Kingsway Fin Services Inc | Gregory P. Hannon | Director | Purchase of securities on an exchange or from another person at price $ 5.31 per share. | 22 Jun 2022 | 34,600 | 2,560,146 (11%) | 0% | 5.3 | 183,678 | Commoon Stock |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 22 Jun 2022 | 33,784 | 117,701 (0%) | 0% | 1.5 | 50,676 | Common Stock |
| John Wiley & Sons Inc (Class A) | Brian A. Napack | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 31,084 | 169,492 | - | - | Restricted Stock Units | |
| PermaPipe International | David J. Mansfield | President & CEO | 22 Jun 2022 | 30,789 | 242,193 (3%) | 0% | 0 | Common Stock | ||
| Block Inc (Class A) | Alyssa Henry | Square Lead | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 30,770 | 30,770 | - | - | Class B Common Stock | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 30,770 | 1,384,610 | - | - | Stock Option (right to buy) | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | 22 Jun 2022 | 30,770 | 464,313 (0%) | 0% | 0 | Class A Common Stock | ||
| Block Inc (Class A) | Alyssa Henry | Square Lead | 22 Jun 2022 | 30,770 | 0 | - | - | Class B Common Stock | ||
| Robinhood Markets Inc (Class A) | Jonathan J. Rubinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,040 | 30,040 | - | - | Restricted Stock Units | |
| Robinhood Markets Inc (Class A) | Robert B. Zoellick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,040 | 30,040 | - | - | Restricted Stock Units | |
| Robinhood Markets Inc (Class A) | Paula Loop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,040 | 30,040 | - | - | Restricted Stock Units | |
| AIxCrypto Holdings Inc | Michael S. Poirier | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 0.57 per share. | 22 Jun 2022 | 30,000 | 199,202 | - | 0.6 | 17,100 | Common Stock |
| Cidara Therapeutics Inc | Daniel D. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Timothy R. Franson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Chrysa Mineo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Bonnie L. Bassler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | David L. Gollaher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Carin Canale-Theakston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| TTM Tech Inc | Catherine A. Gridley | EVP, A&D BU President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 27,593 | 94,542 (0%) | 0% | 0 | Common Stock | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.92 per share. | 22 Jun 2022 | 27,448 | 171,825 | - | 28.9 | 793,933 | Common Stock, $0.01 par value per share |
| Indie Semiconductor Inc (Class A) | David J. Aldrich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 26,965 | 76,965 | - | - | Restricted Stock Units | |
| Indie Semiconductor Inc (Class A) | Jeffrey J. Owens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 26,965 | 76,965 | - | - | Restricted Stock Units | |
| Indie Semiconductor Inc (Class A) | Peter J. Kight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 26,965 | 76,965 | - | - | Restricted Stock Units | |
| Indie Semiconductor Inc (Class A) | Karl-Thomas Neumann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 26,965 | 26,965 | - | - | Restricted Stock Units | |
| Indie Semiconductor Inc (Class A) | Diane D. Brink | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 26,965 | 76,965 | - | - | Restricted Stock Units | |
| Indie Semiconductor Inc (Class A) | Sonalee Parekh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 26,965 | 76,965 | - | - | Restricted Stock Units | |
| Overseas Shipholding Group Inc | Samuel H. Norton | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.07 per share. | 22 Jun 2022 | 25,855 | 1,959,433 (2%) | 0% | 2.1 | 53,520 | Class A Common Stock |
| First Citizens Bancshares Inc (NC) (Class A) | Hope Holding Bryant | Director, Vice Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2022 | 25,400 | 33,833 | - | 0 | Class B Common Stock | |
| Greenwich LifeSciences Inc | Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,008 | 1,073,731 | - | - | Stock Options | |
| Aquestive Therapeutics Inc | Gregory B. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Marco Taglietti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Aquestive Therapeutics Inc | John S. Cochran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| XBiotech Inc | W. Thorpe Mckenzie | Director, Ten Percent Owner | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option | ||
| XBiotech Inc | Donald MacAdam | Director | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option | ||
| XBiotech Inc | Jan-Paul Waldin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option | |
| XBiotech Inc | Peter Libby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Director Stock option | |
| First Citizens Bancshares Inc (NC) (Class A) | Hope Holding Bryant | Director, Vice Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jun 2022 | 23,900 | 53,934 (0%) | 0% | 0 | Class A Common Stock | |
| Biomea Fusion Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,867 | 23,867 | - | - | Stock Option (Right to Buy) | |
| Biomea Fusion Inc | Sumita Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,867 | 23,867 | - | - | Stock Option (Right to Buy) | |
| Biomea Fusion Inc | Bihua Chen | Director, Ten Percent Owner | 22 Jun 2022 | 23,867 | 23,867 | - | - | Stock Option (right to buy) | ||
| Biomea Fusion Inc | Michael J. M. Hitchcock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,867 | 23,867 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Bruce L. Downey | Director | 22 Jun 2022 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | ||
| C4 Therapeutics Inc | Marc A. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Kenneth C. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Malcolm Salter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| ImageneBio Inc | David P. Bonita | Director | Purchase of securities on an exchange or from another person at price $ 3.71 per share. | 22 Jun 2022 | 23,419 | 1,936,097 | - | 3.7 | 86,884 | Common Stock |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 22 Jun 2022 | 22,115 | 442,198 (0%) | 0% | 60 | 1,326,900 | Class A Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.62 per share. | 22 Jun 2022 | 20,850 | 123,557 (0%) | 0% | 10.6 | 221,427 | Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 20,850 | 2,380,400 | - | - | Employee Stock Option (Right to Buy) | |
| EverCommerce Inc | Richard A. Simonson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 20,588 | 20,588 | - | 0 | Common Stock | |
| EverCommerce Inc | Kimberly N. Ellison-Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 20,588 | 20,588 | - | 0 | Common Stock | |
| EverCommerce Inc | Penny Baldwin-Leonard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 20,588 | 20,588 | - | 0 | Common Stock | |
| EverCommerce Inc | Debby Soo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 20,588 | 20,588 | - | 0 | Common Stock | |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Justin Peterson | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.59 per share. | 22 Jun 2022 | 20,000 | 83,201 (0%) | 0% | 20.6 | 411,800 | Class A common stock |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Justin Peterson | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 20,000 | 68,550 | - | - | Stock Option (Right to Buy) | |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Justin Peterson | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 70.27 per share. | 22 Jun 2022 | 20,000 | 63,201 (0%) | 0% | 70.3 | 1,405,334 | Class A common stock |
| Samsara Inc (Class A) | Ann M. Livermore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,821 | 16,821 | - | 0 | Class A Common Stock | |
| Samsara Inc (Class A) | Jonathan C. Chadwick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,821 | 77,852 | - | 0 | Class A Common Stock | |
| Samsara Inc (Class A) | Susan L. Wagner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,821 | 16,821 | - | 0 | Class A Common Stock | |
| Samsara Inc (Class A) | Susan L. Bostrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,821 | 91,821 | - | 0 | Class A Common Stock | |
| Scholar Rock Holding Corp | Amir H. Nashat | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jun 2022 | 16,536 | 16,536 | - | - | Common Warrant (right to buy) | |
| Cullinan Oncology Inc | Thomas Ebeling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,475 | 16,475 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Stephen W. Webster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,475 | 16,475 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Anthony Rosenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,475 | 16,475 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| AdaptHealth Corp | Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 14,970 | 353,907 (0%) | 0% | 0 | Common Stock | |
| Brand House Collective Inc | Ann E. Joyce | Director | 22 Jun 2022 | 14,925 | 20,261 (0%) | 0% | 0 | Common Stock | ||
| Brand House Collective Inc | R. Wilson Orr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 14,925 | 87,453 (0%) | 0% | 0 | Common Stock | |
| Brand House Collective Inc | Susan S. Lanigan | Director | 22 Jun 2022 | 14,925 | 84,453 (0%) | 0% | 0 | Common Stock | ||
| Brand House Collective Inc | Steven J. Collins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 14,925 | 131,243 (0%) | 0% | 0 | Common Stock | |
| Brand House Collective Inc | Charlie Pleas | Director | 22 Jun 2022 | 14,925 | 168,453 (1%) | 0% | 0 | Common Stock | ||
| Brand House Collective Inc | Jeffery Carl Owen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 14,925 | 74,453 (0%) | 0% | 0 | Common Stock | |
| Brand House Collective Inc | Chris L. Shimojima | Director | 22 Jun 2022 | 14,925 | 66,453 (0%) | 0% | 0 | Common Stock | ||
| Brand House Collective Inc | Jill A. Soltau | Director | 22 Jun 2022 | 14,925 | 14,925 (0%) | 0% | 0 | Common Stock | ||
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 141.03 per share. | 22 Jun 2022 | 14,866 | 5,426,512 (1%) | 0% | 141.0 | 2,096,552 | Common Stock |
| TTM Tech Inc | Anthony Joseph Sandeen | President, AMI&I Business Unit | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 13,688 | 36,478 (0%) | 0% | 0 | Common Stock | |
| Intel | Patrick P. Gelsinger | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 13,063 | 47,761 (0%) | 0% | - | Common Stock | |
| Intel | Patrick P. Gelsinger | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 13,063 | 91,446 | - | - | Restricted Stock Units | |
| Quanta Services | Vincent D. Foster | Director | 22 Jun 2022 | 12,948 | 206,925 (0%) | 0% | 118.9 | 1,539,776 | Common Stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 141.84 per share. | 22 Jun 2022 | 12,879 | 5,413,633 (1%) | 0% | 141.8 | 1,826,757 | Common Stock |
| Pagerduty Inc | Owen Howard Wilson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.43 per share. | 22 Jun 2022 | 12,753 | 452,418 (0%) | 0% | 25.4 | 324,309 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 138.16 per share. | 22 Jun 2022 | 11,785 | 5,418,890 (1%) | 0% | 138.2 | 1,628,216 | Common Stock |
| Pagerduty Inc | Owen Howard Wilson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.38 per share. | 22 Jun 2022 | 11,293 | 465,171 (0%) | 0% | 25.4 | 286,666 | Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 74.56 per share. | 22 Jun 2022 | 10,756 | 104,432 (0%) | 0% | 74.6 | 801,967 | Common Stock |
| John Wiley & Sons Inc (Class A) | Christina Van Tassell | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 10,634 | 41,741 | - | - | Restricted Stock Units | |
| Allogene Therapeutics Inc | Owen N. Witte | Director | Sale of securities on an exchange or to another person at price $ 11.76 per share. | 22 Jun 2022 | 10,000 | 233,271 (0%) | 0% | 11.8 | 117,600 | Common Stock |
| Apellis Pharma Inc | David Watson | General Counsel | Sale of securities on an exchange or to another person at price $ 44.51 per share. | 22 Jun 2022 | 10,000 | 115,569 (0%) | 0% | 44.5 | 445,140 | Common Stock |
| Energy Focus Inc | Brian J. Lagarto | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Energy Focus Inc | Brian J. Lagarto | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 10,000 | 0 | - | - | Restricted Stock Units | |
| Energy Focus Inc | Jeffery Robert Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 10,000 | 0 | - | - | Restricted Stock Units | |
| Energy Focus Inc | Jeffery Robert Parker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 135.96 per share. | 22 Jun 2022 | 10,000 | 6,834,880 (1%) | 0% | 136.0 | 1,359,600 | Common Stock |
| Kingsway Fin Services Inc | Terence M. Kavanagh | Director | Purchase of securities on an exchange or from another person at price $ 5.29 per share. | 22 Jun 2022 | 9,699 | 2,512,486 (10%) | 0% | 5.3 | 51,284 | Commoon Stock |
| Kingsway Fin Services Inc | Gregory P. Hannon | Director | Purchase of securities on an exchange or from another person at price $ 5.29 per share. | 22 Jun 2022 | 9,699 | 2,525,486 (11%) | 0% | 5.3 | 51,284 | Commoon Stock |
| TransCode Therapeutics Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 9,500 | 9,500 | - | - | Stock Option (Right to Buy) | |
| TransCode Therapeutics Inc | Erik Manting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 9,500 | 9,500 | - | - | Stock Option (Right to Buy) | |
| TransCode Therapeutics Inc | Philippe P. Calais | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 9,500 | 9,500 | - | - | Stock Option (Right to Buy) | |
| John Wiley & Sons Inc (Class A) | Aref Matin | EVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 9,407 | 52,729 | - | - | Restricted Stock Units | |
| AdaptHealth Corp | Gregory A. Belinfanti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 9,321 | 13,830 (0%) | 0% | 0 | Common Stock | |
| AdaptHealth Corp | Susan T. Weaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 9,321 | 41,894 (0%) | 0% | 0 | Common Stock | |
| AdaptHealth Corp | Terence J. Connors | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 9,321 | 23,339 (0%) | 0% | 0 | Common Stock | |
| AdaptHealth Corp | David S. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 9,321 | 18,339 (0%) | 0% | 0 | Common Stock | |
| AdaptHealth Corp | Theodore Lundberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 9,321 | 13,830 (0%) | 0% | 0 | Common Stock | |
| John Wiley & Sons Inc (Class A) | Todd Zipper | EVP & GM, Education Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 8,691 | 37,589 | - | - | Restricted Stock Units | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Sale of securities on an exchange or to another person at price $ 60.50 per share. | 22 Jun 2022 | 8,655 | 433,543 (0%) | 0% | 60.5 | 523,628 | Class A Common Stock |
| Overseas Shipholding Group Inc | Samuel H. Norton | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 22 Jun 2022 | 8,142 | 1,969,644 (2%) | 0% | 2.1 | 16,935 | Class A Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 137.03 per share. | 22 Jun 2022 | 8,074 | 5,430,675 (1%) | 0% | 137.0 | 1,106,380 | Common Stock |
| Intellicheck Inc | Jeffrey Ishmael | CFO | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 22 Jun 2022 | 8,000 | 45,000 (0%) | 0% | 1.8 | 14,000 | Common Stock, $.001 par value |
| ChargePoint Holdings Inc (Class A) | Rex S. Jackson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 22 Jun 2022 | 7,886 | 1,127,171 | - | 13.6 | 107,478 | Common Stock |
| PermaPipe International | Jerome T. Walker | Director | 22 Jun 2022 | 7,755 | 23,860 (0%) | 0% | 0 | Common Stock | ||
| Overseas Shipholding Group Inc | Samuel H. Norton | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 22 Jun 2022 | 7,457 | 1,932,486 (2%) | 0% | 2.1 | 15,361 | Class A Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 73.64 per share. | 22 Jun 2022 | 6,877 | 115,188 (0%) | 0% | 73.6 | 506,422 | Common Stock |
| PermaPipe International | David B Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 6,842 | 22,437 (0%) | 0% | 0 | Common Stock | |
| PermaPipe International | Robert J. McNally | Director | 22 Jun 2022 | 6,842 | 6,842 (0%) | 0% | 0 | Common Stock | ||
| PermaPipe International | Cynthia Boiter | Director | 22 Jun 2022 | 6,842 | 22,437 (0%) | 0% | 0 | Common Stock | ||
| Domo Inc (Class B) | John F. Mellor | CEO | Sale of securities on an exchange or to another person at price $ 27.30 per share. | 22 Jun 2022 | 6,788 | 379,171 (1%) | 0% | 27.3 | 185,321 | Class B Common Stock |
| Expensify Inc (Class A) | Timothy L. Christen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 6,721 | 16,813 | - | 0 | Class A Common Stock | |
| Expensify Inc (Class A) | Ying Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 6,721 | 16,630 | - | 0 | Class A Common Stock | |
| Expensify Inc (Class A) | Ellen Pao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 6,721 | 16,500 | - | 0 | Class A Common Stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 136.01 per share. | 22 Jun 2022 | 6,697 | 5,438,749 (1%) | 0% | 136.0 | 910,859 | Common Stock |
| Progyny Inc | Norman C. Payson | Director | Sale of securities on an exchange or to another person at price $ 27.35 per share. | 22 Jun 2022 | 6,618 | 451,120 (0%) | 0% | 27.3 | 181,002 | Common Stock |
| John Wiley & Sons Inc (Class A) | Matthew H Leavy | EVP, Academic Prof Learning | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 6,513 | 30,999 | - | - | Restricted Stock Units | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 131.06 per share. | 22 Jun 2022 | 6,500 | 5,445,446 (1%) | 0% | 131.1 | 851,890 | Common Stock |
| Intel | Patrick P. Gelsinger | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.49 per share. | 22 Jun 2022 | 6,477 | 41,284 (0%) | 0% | 37.5 | 242,855 | Common Stock |
| LendingTree Inc | G. Kennedy Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 6,433 | 6,433 | - | - | Stock Options | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 139.05 per share. | 22 Jun 2022 | 6,343 | 5,412,547 (1%) | 0% | 139.0 | 881,994 | Common Stock |
| John Wiley & Sons Inc (Class A) | James Flynn J. | EVP and GM, Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 6,227 | 9,919 | - | - | Restricted Stock Units | |
| PermaPipe International | Grant Dewbre | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 5,930 | 35,652 (0%) | 0% | 0 | Common Stock | |
| SoundThinking Inc | Pascal Levensohn | Director | 22 Jun 2022 | 5,924 | 21,883 (0%) | 0% | 0 | Common Stock | ||
| PermaPipe International | D. Bryan Norwood | Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 5,783 | 30,357 (0%) | 0% | 0 | Common Stock | |
| Privia Health Group Inc | M. Shawn Morris | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.65 per share. | 22 Jun 2022 | 5,522 | 121,739 | - | 29.7 | 163,744 | Common Stock, $0.01 par value per share |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Sale of securities on an exchange or to another person at price $ 19.88 per share. | 22 Jun 2022 | 5,396 | 10,853 | - | 19.9 | 107,256 | Common Stock |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 5,396 | 471,792 | - | - | Options (Rights to Buy) | |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 5,396 | 477,188 | - | - | Options (Rights to Buy) | |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Sale of securities on an exchange or to another person at price $ 20.08 per share. | 22 Jun 2022 | 5,396 | 10,853 | - | 20.1 | 108,365 | Common Stock |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.49 per share. | 22 Jun 2022 | 5,396 | 16,249 | - | 4.5 | 24,228 | Common Stock |
| Agilon Health Inc | Benjamin Kornitzer | Chief Med. & Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.49 per share. | 22 Jun 2022 | 5,396 | 16,249 | - | 4.5 | 24,228 | Common Stock |
| Intellicheck Inc | Jeffrey Ishmael | CFO | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 22 Jun 2022 | 5,100 | 50,100 (0%) | 0% | 1.8 | 8,976 | Common Stock, $.001 par value |
| Energy Focus Inc | Gina Huang | Director, Ten Percent Owner | 22 Jun 2022 | 5,000 | 0 | - | - | Restricted Stock Units | ||
| Energy Focus Inc | Gina Huang | Director, Ten Percent Owner | 22 Jun 2022 | 5,000 | 381,832 (2%) | 0% | 0 | Common Stock | ||
| Energy Focus Inc | Jennifer Y. Cheng | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 0 | - | - | Restricted Stock Units | |
| Energy Focus Inc | Jennifer Y. Cheng | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 22,000 (0%) | 0% | 0 | Common Stock | |
| Energy Focus Inc | Philip Politziner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 0 | - | - | Restricted Stock Units | |
| Energy Focus Inc | Philip Politziner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 31,400 (0%) | 0% | 0 | Common Stock | |
| Energy Focus Inc | Stephen J. Socolof | Director, Chairman and Interim CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 25,500 (0%) | 0% | 0 | Common Stock | |
| Energy Focus Inc | Stephen J. Socolof | Director, Chairman and Interim CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 0 | - | - | Restricted Stock Units | |
| Intelligent Bio Soln Inc | Spiro Sakiris | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 22 Jun 2022 | 5,000 | 50,228 | - | 0.6 | 3,249 | Common Stock |
| Ducommun Inc | Jerry L. Redondo | Sr. Vice President, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,981 | 49,528 (0%) | 0% | 0 | Common Stock | |
| SoundThinking Inc | William J. Bratton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,936 | 21,858 (0%) | 0% | 0 | Common Stock | |
| SoundThinking Inc | Marc H. Morial | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,936 | 22,470 (0%) | 0% | 0 | Common Stock | |
| SoundThinking Inc | Deborah A. Elam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,936 | 7,459 (0%) | 0% | 0 | Common Stock | |
| SoundThinking Inc | Roberta S. Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,936 | 6,882 (0%) | 0% | 0 | Common Stock | |
| SoundThinking Inc | Ruby Sharma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,936 | 6,469 (0%) | 0% | 0 | Common Stock | |
| John Wiley & Sons Inc (Class A) | Danielle McMahan | EVP, Chief People and Bus Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,924 | 23,845 | - | - | Restricted Stock Units | |
| ChargePoint Holdings Inc (Class A) | Michael D. Hughes | See Remarks | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 22 Jun 2022 | 4,790 | 968,065 | - | 13.6 | 65,296 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Michael D. Hughes | See Remarks | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 22 Jun 2022 | 4,790 | 968,065 | - | 13.6 | 65,296 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 140.05 per share. | 22 Jun 2022 | 4,768 | 5,441,378 (1%) | 0% | 140.0 | 667,758 | Common Stock |
| Ducommun Inc | Christopher D. Wampler | VP, CFO, Controller, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,673 | 23,305 (0%) | 0% | 0 | Common Stock | |
| John Wiley & Sons Inc (Class A) | Deirdre P. Silver | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,638 | 16,983 | - | - | Restricted Stock Units | |
| Ducommun Inc | Rajiv A. Tata | V.P., General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,100 | 11,508 (0%) | 0% | 0 | Common Stock | |
| Crexendo Inc | David Tzat-kin Wang | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.94 per share. | 22 Jun 2022 | 4,000 | 422,597 | - | 2.9 | 11,740 | Common Stock |
| Crexendo Inc | David Tzat-kin Wang | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.91 per share. | 22 Jun 2022 | 4,000 | 426,597 | - | 0.9 | 3,640 | Common Stock |
| Crexendo Inc | David Tzat-kin Wang | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 4,000 | 828,453 | - | - | Non-Qualified Stock Options | |
| Array Tech Inc | Erica Brinker | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 22 Jun 2022 | 3,975 | 66,481 | - | 12.5 | 49,811 | Common Stock, par value $0.001 per share |
| iSpecimen Inc | Christopher Ianelli | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.36 per share. | 22 Jun 2022 | 3,903 | 442,743 | - | 2.4 | 9,211 | Common Stock |
| Apogee Enterprises Inc | Donald A. Nolan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 3,565 | 19,791 | - | - | Deferred Restricted Stock Units | |
| Nasdaq | Michael R. Splinter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 3,384 | 69,255 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Asana Inc (Class A) | Tim M. Wan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.20 per share. | 22 Jun 2022 | 3,276 | 609,203 | - | 18.2 | 59,613 | Class A Common Stock |
| Domo Inc (Class B) | Catherine Wong | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 27.26 per share. | 22 Jun 2022 | 3,150 | 299,627 (1%) | 0% | 27.3 | 85,858 | Class B Common Stock |
| iSpecimen Inc | Benjamin Bielak | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.36 per share. | 22 Jun 2022 | 3,148 | 66,348 | - | 2.4 | 7,429 | Common Stock |
| iSpecimen Inc | Jill Mullan | Director, COO and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.36 per share. | 22 Jun 2022 | 3,124 | 197,818 | - | 2.4 | 7,373 | Common Stock |
| Progyny Inc | Norman C. Payson | Director | Sale of securities on an exchange or to another person at price $ 28.76 per share. | 22 Jun 2022 | 3,100 | 446,420 (0%) | 0% | 28.8 | 89,156 | Common Stock |
| Workday (Class A) | George Still | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 3,051 | 159,903 (0%) | 0% | 0 | Class A Common Stock | |
| HireQuest Inc | Richard Hermanns | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.46 per share. | 22 Jun 2022 | 3,000 | 3,454,498 (25%) | 0% | 12.5 | 37,381 | Common Stock |
| LendingTree Inc | G. Kennedy Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,828 | 2,828 | - | - | Stock Options | |
| Apogee Enterprises Inc | Herbert K. Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,773 | 33,955 (0%) | 0% | 0 | Common Stock | |
| Apogee Enterprises Inc | Mark A. Pompa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,773 | 15,911 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc | Frank G. Heard | Director | 22 Jun 2022 | 2,773 | 10,509 (0%) | 0% | 0 | Common Stock | ||
| Apogee Enterprises Inc | Patricia K. Wagner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,773 | 20,321 (0%) | 0% | 0 | Common Stock | |
| Apogee Enterprises Inc | Christina M. Alvord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,773 | 2,773 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,773 | 16,129 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc | Elizabeth M. Lilly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,773 | 11,886 (0%) | 0% | 0 | Common Stock | |
| Overseas Shipholding Group Inc | Samuel H. Norton | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 22 Jun 2022 | 2,752 | 1,972,396 (2%) | 0% | 2.1 | 5,752 | Class A Common Stock |
| iSpecimen Inc | Tracy Curley | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.36 per share. | 22 Jun 2022 | 2,738 | 45,141 | - | 2.4 | 6,462 | Common Stock |
| Workday (Class A) | Christa Davies | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,726 | 166,198 (0%) | 0% | 0 | Class A Common Stock | |
| PC Connection Inc | Patricia Gallup | Director, Chairman & Chief Admin Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.20 per share. | 22 Jun 2022 | 2,700 | 2,104,663 (7%) | 0% | 44.2 | 119,340 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 136.93 per share. | 22 Jun 2022 | 2,620 | 5,449,326 (1%) | 0% | 136.9 | 358,757 | Common Stock |
| CIENA Corp | Rick Dodd | SVP, Software and Services | Sale of securities on an exchange or to another person at price $ 44.06 per share. | 22 Jun 2022 | 2,600 | 68,257 (0%) | 0% | 44.1 | 114,556 | Common Stock |
| Workday (Class A) | Chih-Yuan Jerry Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,564 | 92,544 (0%) | 0% | 0 | Class A Common Stock | |
| Costco Wholesale | James Murphy | Executive VP | Sale of securities on an exchange or to another person at price $ 464.00 per share. | 22 Jun 2022 | 2,500 | 37,730 (0%) | 0% | 464 | 1,160,000 | Common Stock |
| Nasdaq | Steven D. Black | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,440 | 46,823 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq | Thomas Kloet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,440 | 27,343 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Workday (Class A) | Carl M. Eschenbach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,402 | 8,245 (0%) | 0% | 0 | Class A Common Stock | |
| Nasdaq | John David Rainey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,375 | 17,265 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq | Alfred W Zollar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,342 | 10,933 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Workday (Class A) | Lee J. Styslinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,321 | 33,962 (0%) | 0% | 0 | Class A Common Stock | |
| Workday (Class A) | Lynne M. Doughtie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,321 | 6,659 (0%) | 0% | 0 | Class A Common Stock | |
| Salesforce | Marc Benioff | Director, Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 2,300 | 209,716 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Salesforce | Marc Benioff | Director, Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 80.99 per share. | 22 Jun 2022 | 2,300 | 28,763,668 (3%) | 0% | 81.0 | 186,277 | Common Stock |
| Salesforce | Marc Benioff | Director, Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 2,300 | 205,116 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Salesforce | Marc Benioff | Director, Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 80.99 per share. | 22 Jun 2022 | 2,300 | 28,763,668 (3%) | 0% | 81.0 | 186,277 | Common Stock |
| PC Connection Inc | Patricia Gallup | Director, Chairman & Chief Admin Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 43.73 per share. | 22 Jun 2022 | 2,300 | 2,102,363 (7%) | 0% | 43.7 | 100,579 | Common Stock |
| Overseas Shipholding Group Inc | Samuel H. Norton | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 22 Jun 2022 | 2,277 | 1,924,773 (2%) | 0% | 2.1 | 4,668 | Class A Common Stock |
| Workday (Class A) | Ann-Marie Campbell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,240 | 12,474 (0%) | 0% | 0 | Class A Common Stock | |
| ChargePoint Holdings Inc (Class A) | Colleen Jansen | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 22 Jun 2022 | 2,228 | 589,597 | - | 13.6 | 30,368 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Colleen Jansen | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 22 Jun 2022 | 2,228 | 589,597 | - | 13.6 | 30,368 | Common Stock |
| Nasdaq | Essa H. Kazim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,212 | 43,033 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| LendingTree Inc | Mark A. Ernst | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,205 | 2,205 | - | - | Restricted Stock Units | |
| LendingTree Inc | Steven Ozonian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,205 | 2,205 | - | - | Restricted Stock Units | |
| LendingTree Inc | Gabriel Dalporto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,205 | 2,205 | - | - | Restricted Stock Units | |
| LendingTree Inc | Robin Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,205 | 2,205 | - | - | Restricted Stock Units | |
| LendingTree Inc | Saras Sarasvathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,205 | 2,205 | - | - | Restricted Stock Units | |
| LendingTree Inc | Thomas M. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,205 | 2,205 | - | - | Restricted Stock Units | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 138.88 per share. | 22 Jun 2022 | 2,177 | 5,446,146 (1%) | 0% | 138.9 | 302,342 | Common Stock |
| Civitas Resources Inc - Ordinary Shares New | Cyrus D. Marter | General Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.57 per share. | 22 Jun 2022 | 2,143 | 67,643 | - | 62.6 | 134,088 | Common Stock |
| LendingTree Inc | Mark A. Ernst | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,081 | 2,081 | - | - | Stock Options | |
| LendingTree Inc | Steven Ozonian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,081 | 2,081 | - | - | Stock Options | |
| LendingTree Inc | Gabriel Dalporto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,081 | 2,081 | - | - | Stock Options | |
| LendingTree Inc | Robin Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,081 | 2,081 | - | - | Stock Options | |
| LendingTree Inc | Saras Sarasvathy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,081 | 2,081 | - | - | Stock Options | |
| LendingTree Inc | Thomas M. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,081 | 2,081 | - | - | Stock Options | |
| Workday (Class A) | Thomas F. Bogan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,077 | 44,084 (0%) | 0% | 0 | Class A Common Stock | |
| Workday (Class A) | Wayne A.I. Frederick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,077 | 2,077 (0%) | 0% | 0 | Class A Common Stock | |
| Overseas Shipholding Group Inc | Samuel H. Norton | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.07 per share. | 22 Jun 2022 | 2,069 | 1,961,502 (2%) | 0% | 2.1 | 4,293 | Class A Common Stock |
| Quanta Services | Vincent D. Foster | Director | 22 Jun 2022 | 2,000 | 204,925 (0%) | 0% | 119.6 | 239,120 | Common Stock | |
| American Woodmark Corp | Michael Scott Culbreth | PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 41.13 per share. | 22 Jun 2022 | 2,000 | 57,930 (0%) | 0% | 41.1 | 82,261 | Common Stock |
| Intellicheck Inc | Jeffrey Ishmael | CFO | Purchase of securities on an exchange or from another person at price $ 1.83 per share. | 22 Jun 2022 | 2,000 | 56,013 (0%) | 0% | 1.8 | 3,660 | Common Stock, $.001 par value |
| Xcel Energy | Megan D. Burkhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,993 | 1,993 (0%) | 0% | 0 | Common Stock | |
| Bright Horizons Family Soln Inc | David H. Lissy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,948 | 72,610 (0%) | 0% | - | Common Stock | |
| ChargePoint Holdings Inc (Class A) | Rebecca Chavez | General Counsel and Secretary | 22 Jun 2022 | 1,919 | 262,867 | - | 13.6 | 26,152 | Common Stock | |
| Progyny Inc | Norman C. Payson | Director | Sale of securities on an exchange or to another person at price $ 29.52 per share. | 22 Jun 2022 | 1,918 | 444,502 (0%) | 0% | 29.5 | 56,619 | Common Stock |
| John Wiley & Sons Inc (Class A) | Shari Hofer | EVP & Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,918 | 3,344 | - | - | Restricted Stock Units | |
| Civitas Resources Inc - Ordinary Shares New | Dean Tinsley | SVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.57 per share. | 22 Jun 2022 | 1,908 | 48,847 | - | 62.6 | 119,384 | Common Stock |
| Primis Fin Corp | Charles A. Kabbash | Director | Purchase of securities on an exchange or from another person at price $ 13.49 per share. | 22 Jun 2022 | 1,850 | 61,810 (0%) | 0% | 13.5 | 24,964 | Common Stock |
| Nasdaq | Melissa M. Arnoldi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,789 | 12,357 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.88 per share. | 22 Jun 2022 | 1,778 | 209,897 (0%) | 0% | 6.9 | 12,233 | Common Stock |
| SB Fin Grp Inc | Richard L. Hardgrove | Director | Sale of securities on an exchange or to another person at price $ 17.70 per share. | 22 Jun 2022 | 1,761 | 16,328 (0%) | 0% | 17.7 | 31,170 | COMMON STOCK |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 75.12 per share. | 22 Jun 2022 | 1,725 | 102,707 (0%) | 0% | 75.1 | 129,582 | Common Stock |
| Nasdaq | Charlene T. Begley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,692 | 12,153 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Nasdaq | Toni Townes-Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,692 | 2,643 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Matador Resources Co | Robert T. Macalik | EVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 1,667 | 1,667 | - | - | Phantom Units | |
| Matador Resources Co | Brian J. Willey | SVP, President of Midstream | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 1,667 | 1,667 | - | - | Phantom Units | |
| Matador Resources Co | W. Thomas Elsener | EVP, Reservoir Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 1,667 | 1,667 | - | - | Phantom Units | |
| Progyny Inc | Norman C. Payson | Director | Sale of securities on an exchange or to another person at price $ 27.84 per share. | 22 Jun 2022 | 1,600 | 449,520 (0%) | 0% | 27.8 | 44,544 | Common Stock |
| John Wiley & Sons Inc (Class A) | Christopher F. Caridi | SVP, Global Corp Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,579 | 9,560 | - | - | Restricted Stock Units | |
| Intellicheck Inc | Jeffrey Ishmael | CFO | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 22 Jun 2022 | 1,575 | 53,513 (0%) | 0% | 1.8 | 2,835 | Common Stock, $.001 par value |
| Acco Brands Corp | Kathleen S. Dvorak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,571 | 143,651 | - | - | Restricted Stock Units | |
| Crexendo Inc | Steven G. Mihaylo | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.97 per share. | 22 Jun 2022 | 1,500 | 11,178,256 | - | 3.0 | 4,458 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 143.10 per share. | 22 Jun 2022 | 1,487 | 5,412,146 (1%) | 0% | 143.1 | 212,790 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Henrik Gerdes | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 22 Jun 2022 | 1,451 | 121,877 | - | 13.6 | 19,775 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Henrik Gerdes | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 22 Jun 2022 | 1,451 | 121,877 | - | 13.6 | 19,775 | Common Stock |
| Acco Brands Corp | E. Mark Rajkowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,407 | 128,685 | - | - | Restricted Stock Units | |
| John Wiley & Sons Inc (Class A) | Kevin Monaco | SVP, Treasurer & Tax | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,402 | 8,234 | - | - | Restricted Stock Units | |
| Intellicheck Inc | Jeffrey Ishmael | CFO | Purchase of securities on an exchange or from another person at price $ 1.77 per share. | 22 Jun 2022 | 1,400 | 51,500 (0%) | 0% | 1.8 | 2,478 | Common Stock, $.001 par value |
| Salesforce | Gavin Patterson | Pres. & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 1,351 | 10,806 | - | - | Restricted Stock Units | |
| Salesforce | Gavin Patterson | Pres. & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2022 | 1,351 | 16,665 (0%) | 0% | 0 | Common Stock | |
| Acco Brands Corp | Pradeep Jotwani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,327 | 121,318 | - | - | Restricted Stock Units | |
| Bright Horizons Family Soln Inc | Cathy E. Minehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,299 | 6,717 (0%) | 0% | - | Common Stock | |
| Bright Horizons Family Soln Inc | Mary Ann Tocio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,299 | 65,768 (0%) | 0% | - | Common Stock | |
| Bright Horizons Family Soln Inc | Joshua Bekenstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,299 | 7,717 (0%) | 0% | 0 | Common Stock | |
| Bright Horizons Family Soln Inc | Jordan Hitch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,299 | 7,717 (0%) | 0% | - | Common Stock | |
| Bright Horizons Family Soln Inc | Lawrence M. Alleva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,299 | 8,955 (0%) | 0% | - | Common Stock | |
| Bright Horizons Family Soln Inc | Sara Lawrence-Lightfoot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,299 | 6,717 (0%) | 0% | - | Common Stock | |
| Bright Horizons Family Soln Inc | Laurel J. Richie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,299 | 3,708 (0%) | 0% | - | Common Stock | |
| Bright Horizons Family Soln Inc | Julie Atkinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,299 | 6,317 (0%) | 0% | - | Common Stock | |
| Asana Inc (Class A) | Eleanor Lacey | GC, Corporate Secretary | Sale of securities on an exchange or to another person at price $ 18.20 per share. | 22 Jun 2022 | 1,275 | 170,603 | - | 18.2 | 23,201 | Class A Common Stock |
| Salesforce | Gavin Patterson | Pres. & Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 170.43 per share. | 22 Jun 2022 | 1,273 | 16,263 (0%) | 0% | 170.4 | 216,956 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Eric Sidle | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 13.63 per share. | 22 Jun 2022 | 1,268 | 618,003 | - | 13.6 | 17,284 | Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 72.44 per share. | 22 Jun 2022 | 1,265 | 122,065 (0%) | 0% | 72.4 | 91,637 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.